Vera Therapeutics (VERA) News Today $22.07 +0.06 (+0.27%) As of 02:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period HC Wainwright Initiates Coverage on Vera Therapeutics (NASDAQ:VERA)HC Wainwright started coverage on shares of Vera Therapeutics in a research note on Monday. They set a "buy" rating and a $75.00 target price on the stock.May 7 at 11:27 AM | marketbeat.comVera Therapeutics shares fall as Q1 loss exceeds estimatesMay 6 at 7:19 PM | investing.comVera Therapeutics Provides Business Update and Reports First Quarter 2025 Financial ResultsMay 6 at 8:00 AM | globenewswire.comHC Wainwright Begins Coverage on Vera Therapeutics (NASDAQ:VERA)May 6 at 2:47 AM | americanbankingnews.comVera Therapeutics, Inc. (NASDAQ:VERA) Stock Holdings Lessened by Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC lessened its stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 40.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 116,915 shares of the company's stock after selling 79,435 shares during the period.May 5 at 5:10 AM | marketbeat.comVera Therapeutics (VERA) Expected to Announce Earnings on ThursdayVera Therapeutics (NASDAQ:VERA) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-vera-therapeutics-inc-stock/)May 3, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Recommendation of "Buy" from AnalystsVera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) has earned a consensus rating of "Buy" from the ten research firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and three have given a sMay 3, 2025 | marketbeat.comBoothbay Fund Management LLC Acquires New Position in Vera Therapeutics, Inc. (NASDAQ:VERA)Boothbay Fund Management LLC bought a new position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 24,722 shares of the company's stock, vaMay 2, 2025 | marketbeat.comVera Therapeutics (VERA) to Release Quarterly Earnings on ThursdayMay 1, 2025 | americanbankingnews.comVera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Recommendation of "Buy" from BrokeragesMay 1, 2025 | americanbankingnews.comVera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by First Light Asset Management LLCFirst Light Asset Management LLC boosted its stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 78.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,261,246 shares of the company's stock after purchasing an additional 556,012 shares during the peApril 30, 2025 | marketbeat.comRaymond James Financial Inc. Purchases Shares of 69,724 Vera Therapeutics, Inc. (NASDAQ:VERA)Raymond James Financial Inc. acquired a new stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 69,724 shares of the company's stock, valued at approximatelyApril 30, 2025 | marketbeat.comVoya Investment Management LLC Buys 591,682 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA)Voya Investment Management LLC increased its position in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 572.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 695,091 shares ofApril 29, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Reduces Position in Vera Therapeutics, Inc. (NASDAQ:VERA)Adage Capital Partners GP L.L.C. trimmed its holdings in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 65.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 480,000 shares of the companyApril 29, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD grew its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 11.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,377,049 shares of the compApril 29, 2025 | marketbeat.comBarclays PLC Raises Position in Vera Therapeutics, Inc. (NASDAQ:VERA)Barclays PLC grew its holdings in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 16.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 99,148 shares of the company's stock afterApril 29, 2025 | marketbeat.comRenaissance Technologies LLC Makes New Investment in Vera Therapeutics, Inc. (NASDAQ:VERA)Renaissance Technologies LLC acquired a new stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 35,700 shares of the company's stock, valued at approxApril 29, 2025 | marketbeat.comDecheng Capital LLC Reduces Position in Vera Therapeutics, Inc. (NASDAQ:VERA)Decheng Capital LLC decreased its holdings in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 28.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 49,767 shares of the company's stock after selling 20,000April 28, 2025 | marketbeat.comLord Abbett & CO. LLC Increases Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA)Lord Abbett & CO. LLC raised its position in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 170.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,153,670 shares of the company's stock after acquiring an additiApril 28, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Buys 431,178 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA)T. Rowe Price Investment Management Inc. lifted its stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 43.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,415,179 shares of the company'sApril 28, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Shares Acquired by Wells Fargo & Company MNWells Fargo & Company MN increased its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 229.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 39,576 shares of the company's stock after acquiring an addiApril 28, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Shares Sold by Eversept Partners LPEversept Partners LP trimmed its stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 22.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,600,015 shares of the company's stock after selling 450,142 sharApril 24, 2025 | marketbeat.comAvoro Capital Advisors LLC Has $237.25 Million Position in Vera Therapeutics, Inc. (NASDAQ:VERA)Avoro Capital Advisors LLC grew its stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 30.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,610,000 shares of the company's stock after buying an additionApril 23, 2025 | marketbeat.comRock Springs Capital Management LP Boosts Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA)Rock Springs Capital Management LP raised its position in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 27.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 487,863 shares of tApril 23, 2025 | marketbeat.comMarshall Wace LLP Increases Position in Vera Therapeutics, Inc. (NASDAQ:VERA)Marshall Wace LLP grew its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 43.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 837,146 shares of the company's stock after purchasing an additional 253,421 shares during the perioApril 21, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Shares Sold by Altium Capital Management LLCAltium Capital Management LLC reduced its stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 36.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 432,000 shares of the company's stocApril 19, 2025 | marketbeat.comVera Therapeutics (NASDAQ:VERA) Shares Down 2.6% - Should You Sell?Vera Therapeutics (NASDAQ:VERA) Stock Price Down 2.6% - Time to Sell?April 16, 2025 | marketbeat.comGeode Capital Management LLC Has $48.79 Million Stock Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA)Geode Capital Management LLC boosted its position in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 14.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,153,325 shares of the company's stock after purchasing an additional 148,660 shares during the perApril 16, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by JPMorgan Chase & Co.JPMorgan Chase & Co. raised its position in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 71.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 221,485 shares of the company's stock after buying an additional 92,390 sharesApril 16, 2025 | marketbeat.comFmr LLC Increases Position in Vera Therapeutics, Inc. (NASDAQ:VERA)Fmr LLC lifted its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 9.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,053,126 shares of the company's stock after buying an additional 267,842 shares during the period. FmrApril 15, 2025 | marketbeat.comFaster, More Frequent Proteinuria Reduction With Sparsentan in FSGSApril 14, 2025 | msn.com48,593 Shares in Vera Therapeutics, Inc. (NASDAQ:VERA) Purchased by Norges BankNorges Bank bought a new stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 48,593 shares of the company's stock, valued at approximately $2,055,000. Norges Bank owned 0.08% of VeraApril 14, 2025 | marketbeat.comTrexquant Investment LP Sells 29,975 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA)Trexquant Investment LP lessened its stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 57.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,864 shares of the company's stock afterApril 13, 2025 | marketbeat.comVera Therapeutics (NASDAQ:VERA) Trading 5.3% Higher - Time to Buy?Vera Therapeutics (NASDAQ:VERA) Trading Up 5.3% - Should You Buy?April 11, 2025 | marketbeat.comVera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Federated Hermes Inc.Federated Hermes Inc. increased its position in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 162.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,085,986 shares of the company's stock aApril 10, 2025 | marketbeat.comVanguard Group Inc. Acquires 369,387 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA)Vanguard Group Inc. raised its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 14.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,949,564 shares of the company's stock after purchasingApril 10, 2025 | marketbeat.comVera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 9, 2025 | globenewswire.comVera Therapeutics (NASDAQ:VERA) Reaches New 12-Month Low - Here's What HappenedVera Therapeutics (NASDAQ:VERA) Reaches New 52-Week Low - Here's WhyApril 9, 2025 | marketbeat.comSpringhill Fund Asset Management HK Co Ltd Invests $4.63 Million in Vera Therapeutics, Inc. (NASDAQ:VERA)Springhill Fund Asset Management HK Co Ltd bought a new stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 109,400 shares of the compaApril 8, 2025 | marketbeat.comGuggenheim Reaffirms Their Buy Rating on Vera Therapeutics (VERA)April 7, 2025 | markets.businessinsider.comVera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of "Buy" from AnalystsVera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) has earned a consensus rating of "Buy" from the ten analysts that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and three haveApril 7, 2025 | marketbeat.comCinctive Capital Management LP Buys 65,046 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA)Cinctive Capital Management LP boosted its stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 134.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 113,546 shares of the compApril 5, 2025 | marketbeat.comVera Therapeutics completes enrollment in ORIGIN Phase 3 trial for ataciceptApril 3, 2025 | markets.businessinsider.comVera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgANApril 3, 2025 | markets.businessinsider.comVera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgANApril 3, 2025 | globenewswire.comPrudential Financial Inc. Grows Position in Vera Therapeutics, Inc. (NASDAQ:VERA)Prudential Financial Inc. grew its stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 33.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 83,077 shares of the company's stock after aApril 3, 2025 | marketbeat.comVera Therapeutics (NASDAQ:VERA) Reaches New 52-Week Low - Here's WhyVera Therapeutics (NASDAQ:VERA) Sets New 52-Week Low - What's Next?April 2, 2025 | marketbeat.comAmerican Century Companies Inc. Has $18.14 Million Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA)American Century Companies Inc. grew its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 11.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 428,940 shares of theApril 2, 2025 | marketbeat.comVera Therapeutics (NASDAQ:VERA) Shares Gap Down - Should You Sell?Vera Therapeutics (NASDAQ:VERA) Shares Gap Down - Here's WhyApril 1, 2025 | marketbeat.comPictet Asset Management Holding SA Boosts Stock Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA)Pictet Asset Management Holding SA increased its position in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 47.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 841,313 shares of the company's stock aftApril 1, 2025 | marketbeat.com Get Vera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter. Email Address VERA Media Mentions By Week VERA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VERA News Sentiment▼0.730.64▲Average Medical News Sentiment VERA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VERA Articles This Week▼125▲VERA Articles Average Week Get Vera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sarepta Therapeutics News Today Telix Pharmaceuticals Limited American Depositary Shares News Today ADMA Biologics News Today Blueprint Medicines News Today Verona Pharma News Today Nuvalent News Today Axsome Therapeutics News Today Grifols News Today Cytokinetics News Today Krystal Biotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VERA) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredYour Wealth is Being Erased – Save It Before It’s Gone ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VERA Stock Free VERA Stock Alerts